Hyperuricemia

"Hyperuricemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Descriptor ID	D033461
MeSH Number(s)	C23.550.449
Concept/Terms	Hyperuricemia Hyperuricemia

Below are MeSH descriptors whose meaning is more general than "Hyperuricemia".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Hyperuricemia [C23.550.449]

Below are MeSH descriptors whose meaning is related to "Hyperuricemia".

Below are MeSH descriptors whose meaning is more specific than "Hyperuricemia".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hyperuricemia" by people in this website by year, and whether "Hyperuricemia" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2014	1	0	1
2015	1	0	1
2016	1	0	1
2019	2	0	2
2020	0	1	1
2021	1	0	1
2022	1	0	1
2023	1	0	1

Below are the most recent publications written about "Hyperuricemia" by people in Profiles.

Wen YF, Brundage RC, Roman YM, Culhane-Pera KA, Straka RJ. Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia. Br J Clin Pharmacol. 2023 10; 89(10):2964-2976.

View in: PubMed
Roman YM. Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices. Nutrients. 2022 Aug 31; 14(17).

View in: PubMed
Roman YM, Lor K, Xiong T, Culhane-Pera K, Straka RJ. Gout prevalence in the Hmong: a?prime example of health disparity and the role of community-based genetic research. Per Med. 2021 05; 18(3):311-327.

View in: PubMed
Roman Y, Tiirikainen M, Prom-Wormley E. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort. Clin Rheumatol. 2020 Aug; 39(8):2387-2392.

View in: PubMed
Eun Y, Han KD, Kim DH, Kim IY, Park EJ, Lee S, Cha HS, Koh EM, Lee J, Kim H. Association between anemia and hyperuricemia: results from the Korean National Health and Nutrition Examination Survey. Sci Rep. 2019 12 13; 9(1):19067.

View in: PubMed
Roman YM. The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia. Hawaii J Med Public Health. 2019 02; 78(2):71-76.

View in: PubMed
Zheng Z, Harman JL, Coresh J, K?ttgen A, McAdams-DeMarco MA, Correa A, Young BA, Katz R, Rebholz CM. The Dietary Fructose:Vitamin C Intake Ratio Is Associated with Hyperuricemia in African-American Adults. J Nutr. 2018 03 01; 148(3):419-426.

View in: PubMed
Saddekni MB, Saag KG, Dudenbostel T, Oparil S, Calhoun DA, Sattui SE, Feig DI, Muntner P, Redden DT, Foster PJ, Rahn EJ, Biggers SR, Li P, Gaffo AL. The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale. Contemp Clin Trials. 2016 09; 50:238-44.

View in: PubMed
Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015 May 19; 131(20):1763-71.

View in: PubMed
Liu H, Zhang XM, Wang YL, Liu BC. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol. 2014 Dec; 27(6):653-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals